News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2202 results

MSD accuses university of patent contract breach

US01-12-2022Staff Writer

Ex-partners collaborated on a clinical study for a cancer treatment | Pharma firm insists that it has exclusive licensing rights | MSD | John Hopkins.

Tribal business settles Stanford opioid treatment clash

US29-11-2022Staff writer

Dispute centred on patented data to treat opioid addiction | Tribe said it had shared confidential data to develop a cure | Stanford University.

USITC launches drug research patents probe

US28-11-2022Staff Writer

German biopharma company’s complaint against Palo Alto competitor prompts commission to investigate | Patents in dispute relate to bio-layer interferometry.

TTAB cuts down fruit breeder TM bid

US24-11-2022Staff Writer

Conflict with name of patents for grapes and cherries prompts denial | If permitted, mark would “impede free use in the marketplace of a varietal denomination” following the patent’s expiration.

Amarin appeals ‘skinny label’ loss

US23-11-2022Staff Writer

Generic heart drug was found to not infringe Amarin’s blockbuster treatment earlier this year | Health insurer Health Net tied to case after allegedly promoting use of the generic.

MSD makes $1.4bn bid on biopharma company

US22-11-2022Staff Writer

Move could garner ‘milestone’ treatment for one of MSD’s portfolios | Activity comes after a Spanish watchdog fined the pharma firm $39 million.

California firm entices quartet of litigators from rival

US17-11-2022Muireann Bolger

Life sciences practice boosted by four-partner ‘powerhouse’ team | Attorneys have all achieved notable trial outcomes for pharma companies.

FTC wades into escalating ‘Orange Book’ clash

US15-11-2022Staff Writer

Jazz accused a rival of infringement | Avadel filed a counterclaim seeking to delist the patent from the Orange Book.

SCOTUS agrees to hear Amgen revival bid

US07-11-2022Staff Writer

The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.

Biotech escalates genetic analysis tech dispute

US24-10-2022Staff Writer

The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Showing 1 to 10 of 2202 results

LSIPR